Mangoceuticals, Inc. Common Stock (MGRX) — Net Asset Quality Index
Mangoceuticals, Inc. Common Stock (MGRX) has a Net Asset Quality Index of 95.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $16.53 Million minus total liabilities of $804.27K yields net assets of $15.73 Million. A higher index indicates a stronger, lower-leverage balance sheet. See MGRX days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Mangoceuticals, Inc. Common Stock Net Asset Quality Index Over Time (2021–2024)
This chart shows how Mangoceuticals, Inc. Common Stock's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the index stands at 95.1%, representing net assets of $15.73 Million against total assets of $16.53 Million USD. Explore Mangoceuticals, Inc. Common Stock operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Mangoceuticals, Inc. Common Stock (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for Mangoceuticals, Inc. Common Stock from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see MGRX market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 90.7% | $13.95 Million | $15.37 Million | $1.43 Million | ▲ +17.0 pp |
| 2023 | 73.7% | $774.75K | $1.05 Million | $276.04K | ▲ +12.5 pp |
| 2022 | 61.2% | $614.03K | $1.00 Million | $389.26K | ▲ +135.3 pp |
| 2021 | -74.1% | $-16.72K | $22.55K | $39.27K | — |